CSL Agrees to Settle U.S. Class-Action Litigation – NASDAQ
|
CSL Agrees to Settle U.S. Class-Action Litigation
NASDAQ MELBOURNE, Australia–Australian vaccines and human-plasma products producer CSL Ltd. (CSL.AU) said it has agreed to settle longrunning antitrust class-action litigation in the U.S. with a deal that will include a payment of US$ 64 million. The … |
